RENOVARO INC. - COMMON STOCK

Statement of Renovaro Inc

14 فبراير 2024 10:01:30 بحسب Nasdaq GlobeNewswire

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

13 فبراير 2024 09:46:07 بحسب Nasdaq GlobeNewswire

AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

13 فبراير 2024 09:31:09 بحسب Nasdaq GlobeNewswire

Renovaro Biosciences Announces Results of Special Meeting of Shareholders

25 يناير 2024 12:45:00 بحسب Nasdaq GlobeNewswire

Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD

16 يناير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors

11 أكتوبر 2023 09:25:00 بحسب Nasdaq GlobeNewswire

Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors

10 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD

02 أكتوبر 2023 12:05:40 بحسب Nasdaq GlobeNewswire

AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine

02 أكتوبر 2023 09:25:00 بحسب Nasdaq GlobeNewswire

Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine

29 سبتمبر 2023 09:15:00 بحسب Nasdaq GlobeNewswire

Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort

30 أغسطس 2023 09:15:00 بحسب Nasdaq GlobeNewswire

Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer

21 أغسطس 2023 09:15:00 بحسب Nasdaq GlobeNewswire

AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer

09 أغسطس 2023 09:00:00 بحسب Nasdaq GlobeNewswire

Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting

23 يونيو 2023 17:00:00 بحسب Nasdaq GlobeNewswire

Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

08 يونيو 2023 08:45:00 بحسب Nasdaq GlobeNewswire

Enochian BioSciences’ CEO Letter to Shareholders

03 أبريل 2023 09:00:00 بحسب Nasdaq GlobeNewswire

Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

29 مارس 2023 09:00:00 بحسب Nasdaq GlobeNewswire

Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

13 مارس 2023 08:30:00 بحسب Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022

23 فبراير 2023 16:04:00 بحسب Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

30 نوفمبر 2022 17:20:12 بحسب Nasdaq GlobeNewswire